SOFWAVE MEDICAL LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,720 ILa | +0.76% |
|
-8.99% | +25.36% |
| Mar. 06 | SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 12 | SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer | CI |
| Sales 2022 | 35.63M 13.2B | Sales 2023 | 50.32M 18.64B | Capitalization | 132M 48.85B |
|---|---|---|---|---|---|
| Net income 2022 | -19M -7.04B | Net income 2023 | -8M -2.96B | EV / Sales 2022 | 1.41 x |
| Net cash position 2022 | 30.08M 11.15B | Net cash position 2023 | 23.09M 8.56B | EV / Sales 2023 | 2.16 x |
| P/E ratio 2022 |
-4.08
x | P/E ratio 2023 |
-15.7
x | Employees | 117 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 37.86% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.76% | ||
| 1 week | -8.99% | ||
| Current month | -3.32% | ||
| 1 month | -8.95% | ||
| 6 months | +90.01% | ||
| Current year | +25.36% |
1 week
1 680.00
1 900.00
1 month
1 680.001 970.00
Current year
1 412.002 130.00
1 year
695.002 130.00
3 years
695.003 799.00
5 years
695.003 799.00
10 years
695.003 799.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ariel Sverdlik
FOU | Founder | 55 | 15-01-26 |
Louis P. Scafuri
CEO | Chief Executive Officer | 72 | 19-06-30 |
Assaf Korner
DFI | Director of Finance/CFO | 46 | 21-09-11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shimon Eckhouse
FOU | Founder | 79 | 15-01-26 |
Yoav Moshe Sebba
BRD | Director/Board Member | 53 | 19-06-30 |
| Director/Board Member | 81 | 18-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-02 | 1,720 | +0.76% | 166,352 |
| 24-05-01 | 1,707 | -4.05% | 24,604 |
| 24-04-30 | 1,779 | -5.87% | 70,483 |
| 24-04-25 | 1,890 | -1.46% | 4,422 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 02, 2024 at 10:24 am EDT
More quotes
Sofwave Medical Ltd, formerly known as Archimedus Medical Ltd, is an Israel-based medical device manufacturer and medical software publisher. The Company operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The Company has subsidiary in United States -Sofwave Medical Inc.
Calendar
2024-05-08
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +25.36% | 159M | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.8B | |
| +3.45% | 51.05B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B |
- Stock Market
- Equities
- SOFW Stock
